Live Breaking News & Updates on Annette Matthies

Stay updated with breaking news from Annette matthies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Form 8-K Elicio Therapeutics, For: Oct 19

Form 8-K Elicio Therapeutics, For: Oct 19
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Annette Matthies , Robert Connelly , Elicio Therapeutics Inc , Securities Exchange , Commission File Number , Securities Exchange Act , General Instruction , Securities Act , Exchange Act , Trading Symbol , Certain Officers , Compensatory Arrangements , Elicio Therapeutics , Chief Business Officer , Release Agreement , Separation Agreement , Separation Date , Page Interactive Data File , Chief Executive Officer , Principal Executive Officer ,

CEPI's founding CEO to lead Wellcome—Chutes & Ladders

CEPI's founding CEO to lead Wellcome—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United States , Garvin Yang , Jon Garfield , Annette Matthies , Neil Mcfarlane , Bruce Harmon , Eli Lilly , Lee Swem , Neil Campbell , Kanvas Biosciences , Robert Lenz , Angion Biomedica , Mark Gergen , John Kovach , Sakura Minami , Christal Mickle , Humphrey Gardner , Gabrielle Masson , Evelo Biosciences , Kristin Yarema , Sarah Thayer , Max Bayer , Tom Garner , Jeffrey Lawson , Bristol Myers Squibb , Lixte Biotechnology Holding ,

Form 8-K Elicio Therapeutics, For: Oct 05

Form 8-K Elicio Therapeutics, For: Oct 05
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Annette Matthies , Robert Connelly , Commission File Number , Securities Exchange , Elicio Therapeutics Inc , Securities Exchange Act , General Instruction , Securities Act , Exchange Act , Trading Symbol , Certain Officers , Compensatory Arrangements , Chief Business Officer , Elicio Therapeutics , Page Interactive Data File , Chief Executive Officer , Principal Executive Officer ,

Chutes & Ladders—After Verastem pit stop, bluebird vet Neumann lands at Kite

Editas Medicine
James Mullen takes over as CEO from Feb. 15.
Editas chairman Mullen will don the CEO mantle Feb. 15, taking over for current Editas chief
Cynthia Collins. Before jumping to the Editas team, Mullen was CEO and director of the CDMO Patheon later snapped up by Thermo Fisher and also served as the CEO of Biogen. In a brief release, Editas didn’t say why Collins was leaving. “It has been a privilege to lead Editas Medicine and this extremely talented team,” she said in a statement. “I am particularly proud of the progress to the clinic we have made with both in vivo and ex vivo gene edited medicines.” Collins joined Editas in 2019, picking up the role from ....

New York , United States , British Columbia , United Kingdom , Bryan Lake , San Francisco , Bhardwaj Desai , Cynthia Collins , Penrose Therapeutx , Daniel Lynch , Shannon Blalock , Fraiser Kansteiner , Eli Lilly , Patrick Mccall , Josh Smiley , Joel Sendek , Tim Trost , Isaac Ro , Guowei Fang , Charlie Newton , Lyell Immunopharma , Manny Duenas , Geoffrey Mcdonough , James Priour , David Enloe , Terry Coelho ,